Power to control bleeding

Power to heal

Save blood, save lives

BloodSTOP iX®

Next Generation Wound Care Products for the World

LifeScience PLUS is a leading, advanced wound care technology company committed to developing and marketing innovative total wound care solutions: hemostasis (bleeding control), sealant, moist dressing, contamination prevention, and fast tissue growth generation.  Our patented best-in-class flagship product BloodSTOP® iX Advanced Hemostat and WoundHEAL® is revolutionary technology for both acute and chronic wound care. BloodSTOP® iX Was Awarded For “Best In Category for Hemostat and Wound Healing” on Burn Wound Donor Site by 51st American Burn Association 2019.

Applications for this technology are numerous.  Our primary focus is for medical professionals during surgical procedures, including burn and trauma surgeries, treatment of ulcer wounds, pre-hospital and emergency trauma wound care.

Trauma Care

Burn Surgery

Medical/Surgical

Dentistry & Oral Surgery

Sports Medicine

Consumer

Our Products

The BloodSTOP® product family is a leading new generation of wound care products for surgery, emergency trauma care, paramedics, ulcers, and dental wounds. This advanced technology provides power to control bleeding and power to heal.

BloodSTOP® and BloodSTOP® iX are biocompatible, non-irritating, natural plant based materials. Upon meeting blood or body exudates, they adhere to a wound, initiate blood coagulation, stop bleeding fast, and form a protective membrane layer which creates an optimal environment for fast wound healing. Their water solubility allows for removal by rinsing, without disruption of a clotted surface.

LSP Online Store Launch, Including Surgical Masks!

LifeScience PLUS is pleased to announce the launch of the BloodSTOP online store.  You can order all of LSP’s revolutionary wound care products from this site faster and easier than before, with additional methods of payment, including all credit cards.  Go to...

School Reopening: Are You Ready?

Schools in United States have been closed for over two months since the outbreak of COVID-19. According to Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, it might be time to consider reopening schools based on the level of...

Slow Acceptance of Masks in US

COVID-19 pandemic has much increased the masks presence in public. However, some people still refuse to wear a facemask because it is not a culture norm in the United States, and they feel strongly about their personal liberty, according to SFChronicle. Infectious...

Future Events

Come join us at the following events and meet and talk with your LifeScience Plus, Inc. Representative(s)!
Sep
9
Wed
The 79th Annual Meeting of American Association for the Surgery of Trauma & Clinical Congress of Acute Care Surgery @ Hilton Waikoloa Village
Sep 9 – Sep 12 all-day
Feb
14
Sun
5th World Trauma Congress @ Brisbane Convention & Exhibition Centre
Feb 14 – Feb 18 all-day

Dr. Stathis Poulakidas, MD, FACS
Division Chief of Burn Surgery
Cook County Health Burn Center, Chicago, IL

View Full Testimonial

A 9 year old female with unknown genetic disorders presented after multiple treatments of open wounds of the scalp, abdomen and leg. Attempts at using Sulfamylon, Aquacel AG, Silvadene, and Gentian Violet yielded no improvement.

The most worrisome component of the patent’s care was the weekly cleanings in which the patient bled over 500cc’s, requiring transfusion of 2 units of blood at every OR visit.

With the introduction of BloodSTOP® iX, wound debridments were able to be done limiting blood loss to <200cc’s and only requiring one unit or a partial unit of blood.

With good wound care, decrease of infections secondary to IV antibiotics and improved nutritional status, wounds started healing. Without the use of BloodSTOP® iX, any type of debridement and cleaning of these wounds would not have been possible at one OR sitting.

To conclude, all prior treatments failed to stop the bleeding for the patient’s head, chest and legs. However, her situation was controlled with BloodSTOP® iX.

View More Testimonials

Dr. Ibrahim H Amjad, MD Plastic Surgeon, Miami Children’s Hospital, Miami, FL